Online DRAP Med Vigilance System
Online Drug Regulatory Information System (GS-I)
Online National Registry of Cardiac Stent
Online Provisional List of Drugs Registered

Our Lead Team

Mr.Muhammad Yusuf Shaikh
Minister For National Health Services, Regulations and Coordination
Captain (r) Zahid Saeed Secretary,Ministry of National Health Services, Regulations and Coordination
Dr. Sheikh Akhter Hussain
Chief Executive Officer (CEO),Drug Regulatory Authority of Pakistan
Readmore

News Updates

Printing of 2D Barcode on Packaging Of Registered Drugs by Orders Of Honorable Supreme Court Click here
Notification - DRAP’s National Task Force for eradication of spurious and unregistered Click here
Tender Notice for IT Equipment Click here
Grievances Redressal Committee Constituted Click here
Import requirement for drugs for personal use of patient [under rule 13 of The Drugs (Import & Export) Rules, 1976, of Drug Act, 1976] Click here
NOTIFICATION-SRO 307(I)/2017 Amendments in the Drugs(Labelling and Packing) Rules,1986 Click here

What we do..


Drug Regulatory Authority of Pakistan (DRAP) is continously improving for effectively, regulating, facilitating, implementing and enforcing compliances in the field of drugs, biologics, devices, alternate medicines and health products..
PATIENT CARE THROUGH HIGH PROFESSIONAL, EFFECTIVE AND SINCERE SERVICES

Safety information

Abbott Vascular Absorb Bioresorbable Vascular Scaffold (BVS)

Safety alert - Increased rate of major adverse cardiac events observed in patients receiving Bioresorbable Vascular Scaffold (BVS)

Testing of 171,375 samples ensured under campaigns to curb spurious drugs sale

DRAP, as part of its special campaigns against spurious drugs in the country, has ensured testing of 1,71,375 samples at its laboratories during two years and nine months

EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity

Some valsartan medicines being recalled across the EU

DRAP Reviewing Medicines Containing Valsartan From Zehijiang Huahai

Following detection of Carcinogenic Impurity

Navigate to..

Pharmaceutical Evaluations and Registration Division is responsible for the evaluation, assessment and registration of pharmaceuticals drugs for human beings, animals and to perform other functions connected therewith and assigned by the Board.

Medical Devices and Medicated Cosmetics Division shall be responsible for the assessment, enlistment or registration of medical devices and medicated cosmetics, medicated shampoos and medicated soaps for human beings, animals and to perform other functions connected therewith
Biological Drugs Division shall be responsible for the evaluation, assessment, registration and licensing of Biologicals for human beings, animals and to perform other functions connected therewith including all the functions of national control authority for biologicals as required for the prequalification by World Health Organizations of locally manufactured human biological drugs
Costing and Pricing Division shall be responsible for the costing and pricing of therapeutic goods and to perform other functions connected therewith
Budget and Accounts Division shall be responsible for budgetary and financial aspects of the Authority and other daily accounting matters connected therewith or ancillary thereto
Legal Affairs shall be responsible for legal aspects of the Authority and other matters connected with Drug Court and other court cases therewith or ancillary thereto.
Drug Licensing Division shall be responsible for the licensing of the drugs manufacturing facilities and to perform other functions connected therewith.
Quality Assurance and Laboratory Testing Divisionshall be responsible for enforcement of current Good Manufacturing Practices under the Act, and for testing or research of drugs and to perform other functions connected therewith. The Division will also perform the functions related to post marketing surveillance and shall be responsible for the evaluation, coordination and monitoring of safety, efficacy and quality of registered drugs and inactive materials including the clinical and toxicological study, drug recalls and with drawls, and to perform other functions connected therewith.
Health and OTC Products (non-drugs Division shall be responsible for the assessment, licensing and registration of Alternative Medicines such as Ayurvedic, Chinese, Unani and Homeopathy, enlistment or registration of nutritional products and food supplements for human beings, animals and to perform other functions connected therewith.